Manuscripts, White Papers, and Poster Presentations/Misc.

Please email Dr. Karr for white paper's

Manuscripts

1. Karr, JC, Lautetta J. In Vitro Anti-fungal Disc Activity of Calcium Sulfate and Hydroxyapatite (Cerament™| Bone Void Filler) Loaded with Amphotericin B or Voriconazole for Consideration in Adjunctive Osteomyelitis Management. Submitted to JAPMA August 2012.

2.     Karr JC, Pham T. A Case Presentation of the Successful Management of Complicated Wounds in the presence of an Infected Knee Prosthesis with Silver Antimicrobial Negative Pressure Dressing and A Negative Pressure Wound Therapy Device. Submitted to Wounds July 2012.

3. Karr, JC. Management in the Wound Care Center Out Patient Setting of a Diabetic Patient Presenting with Forefoot Osteomyelitis Utilizing Cerament™ |Bone Void Filler Impregnated with Vancomycin– Off Label Use.  Journal of American Podiatric Medical Association 2011.    

4.  Karr, JC, Keriazes G, Lautetta J. In Vitro Antimicrobial Activity of Calcium Sulfate and Hydroxyapatite (Cerament™| Bone Void Filler) Discs Utilizing Heat Sensitive and Heat Non-Sensitive Antibiotics against Methicillin Resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Journal of American Podiatric Medical Association Journal.  Vol 101, No. 2, March/April 2011.
    
5.  16.   Karr, JC. Management of a Diabetic Patient Presenting with Forefoot Osteomyelitis: The use of Cerament™ |Bone Void Filler Impregnated with Vancomycin – An off Label Use.  The Journal of Diabetic Foot Complications: 2009, 1 (4), No. 3. pp. 94-100.

6.  Karr, JC.  External Thermoregulation of Wounds Associated With Lower Extremity Osteomyelitis: A Pilot Study.  Vol. 93 No. 1 JAPMA  Pp 18-22 2003

7.  Karr JC.  Diagnosis and management of osteomyelitis.  Wound, Ostotomy, Continence    
Nursing Secrets. Hanley and Belfus Inc.  Philadelphia, 2002.

White Papers

1.  Karr, JC. Case Study: Percutaneous antibiotic delivery Technique – calcaneal osteomyelitis.  The Osteomyelitis Center of Central Florida at The Wound Care Center and HBOT at Lakeland Regional Medical Center.  Newsletter Winter 2012.

2.  Karr, JC.  Fore-foot osteomyelitis with a diabetic ulcer.  The Wound Care Center and HBOT at Lakeland Regional Medical Center.  Newsletter Summer 2011.

3. Karr, JC.  Chronic Tibial Osteomyelitis with an ulcer.  The Wound Care Center and HBOT at Lakeland Regional Medical Center.  Newsletter Summer 2011.

4.  Karr, JC.  Mid-foot Charcot foot with osteomyelitis and diabetic ulcers.  The Wound Care Center and HOBT at Lakeland Regional Medical Center.  Newsletter Summer 2011.

5. Case One: Fibular Osteomyelitis Following Ankle Surgery, Management with Flowable Percutaneous Calcium Sulfate and Hydroxyapitite (Cerament Bone Void Filler) and Vancomyacin. White paper.  
 Bone Support.  January 2011.

6. Case Two:  Calcaneal Osteomyelitis Following Elective Foot Surgery and Management with Flowable Percutaneous Calcium Sulfate and Hydroxyapitite (Cerament Bone Void Filler) with Tobramycin and Vancomyacin. White paper.   Bone Support.  February 2011.

7.  Case Three: The Management of Infected Ankle Arthrodesis with Removal of Internal Fixation and Intra-osseous Delivery of Calcium Sulfate and Hydroxyapitite (Cerament Bone Void Filler) with Vancomyacin. Bone Support.  March 2011. 

8.  Case Five:  Mid-foot Charcot deformity with Osteomyelitis and Diabetic Foot Ulcers: Management with   Flowable Percutaneous Calcium Sulfate and Hydroxyapitite (Cerament Bone Void Filler) with Vancomyacin. Bone Support. April 2011.

9. Karr, JC. Management of a Diabetic Patient Presenting with Forefoot Osteomyelitis Utilizing 
Cerament™|Bone Void Filler Impregnated with Vancomycin– Off Label Use. White paper.  
Bone Support. June 2009.

Misc.

1.  Karr, JC, Keriazes G, Lautetta J. In Vitro Antimicrobial Activity of Calcium Sulfate and Hydroxyapatite (Cerament™| Bone Void Filler) Discs Utilizing Heat Sensitive and Heat Non-Sensitive Antibiotics against Methicillin Resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.  Featured on medlinx.com April 2011.

2.   Karr, JC, Kaleta JL, The diagnosis of Osteomyelitis in the diabetic using Erythrocyte Sedimentation Rate.  Vol  92 No 5 JAPMA Pp 314-315 2002.

3.  Principle investigator, External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis, Pilot Study. Augustine Medical Inc.  2001.

4. Principle investigator, External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis, Main Study. Augustine Medical Inc.  2001.

5. Karr, JC, Keriazes G, Lautetta J. IN VITRO ANTIMICROBIAL ACTIVITY OF CALCIUM SULFATE AND HYDROXYAPATITE DISC OF HEAT SENSITIVE AND HEAT NON-SENSITIVE ANTIBIOTICS AGAINST METHICILLIN RESISTANT STAPHLOCOCCUS AUREUS (MRSA) AND PSEUDOMONAS AERUGINOSA.  European Bone and Joint Infectious Disease Society. September 14-17, 2011 Copenhagen, Denmark.

6. Karr, JC, Loret, De Mola F, Tooke, L The benefit of cryopreserved human fibroblast-derived dermasubstitute, Dermagraft®, in the management of diabetic foot ulcers with underlining osteomyelitis, a ten case series presentation.  SAWC Spring. April 14-17.  Dallas, Texas. 

7. Karr JC, Keriazes G, Lautetta J.  Biocompatible, Injectable Ceramic Antibiotic Impregnated Bone Substitute (Cerament) Minimal Inhibitory Concentration Against Methacillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.  APMA Nation meeting. Toronto, Canada.  July 2009. 

8.   Karr, JC.  Bi-Layered Cell Skin Substitute * Utilization in Foot Ulcers with  Underlining Osteomyelitis.  SAWC.  San Diego, California 2008.

9.  Karr, JC.  Bi-Layered Cell Skin Substitute * Utilization in Foot Ulcers with Underlining Osteomyelitis.  APWCA. Fort Worth, Texas. March 2008.

10. Karr JC.  External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis: An Open Labeled, Controlled, Comparative, and Randomized Study of 40 Patients..  Joint conference of the Wound Healing Society and the European Tissue Repair Society. Seattle, Washington.  May 2003.

11. Karr JC.  External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis: An Open Labeled, Controlled, Comparative, and Randomized Study of 40 Patients.  The 16th Annual Symposium on Advanced Wound Care and Medical Research Forum on Wound Care.  Las Vegas, Nevada.  April 2003.

12.  Karr JC.  External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis: A Pilot Study.  The 17th Annual Clinical Symposium on Advances in Skin and Wound Care. Dallas, TX. September 2002.

13.  Karr JC.  External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis: A Pilot Study.  Joint conference of the Wound Healing Society and the European Tissue Repair Society. Baltimore, MD.  May 2002.

14.  Karr JC.  External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis: A Pilot Study.  The 15th Annual Symposium on Advanced Wound Care and Medical Research Forum on Wound Care.  Baltimore, MD.  April 2002.

15. Karr JC.  External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis: A Pilot Study.  The Diabetic Foot Update 2001.  December, 2001.   San Antonio Texas.

16.   Karr, JC.  External Thermoregulation of Wounds Associated with Lower Extremity Osteomyelitis: A Pilot Study.  The 16th Annual Clinical Symposium on Advances in Skin and Wound Care. Orlando, FL. September 2001.

17.  Karr JC.  Treatment of a venous stasis ulceration with underling tibial osteomyelitis utilizing warm-up therapy ®.  The 14th Annual Symposium on Advanced Wound Care and Medical Research Forum on Wound Care.  Las Vegas, Nevada.  April  2001.